Full text
PDFPage 484
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BOLINGER R. E., MORRIS J. H., MCKNIGHT F. G., DIEDERICH D. A. DISAPPEARANCE OF I-131-LABELED INSULIN FROM PLASMA AS A GUIDE TO MANAGEMENT OF DIABETES. N Engl J Med. 1964 Apr 9;270:767–770. doi: 10.1056/NEJM196404092701504. [DOI] [PubMed] [Google Scholar]
- Cremer G. M., Molnar G. D., Taylor W. F., Moxness K. E., Service F. J., Gatewood L. C., Ackerman E., Rosevear J. W. Studies of diabetic instability. II. Tests of insulinogenic reserve with infusions of arginine, glucagon, epinephrine, and saline. Metabolism. 1971 Dec;20(12):1083–1098. doi: 10.1016/0026-0495(71)90033-3. [DOI] [PubMed] [Google Scholar]
- Dixon K., Exon P. D., Hughes H. R. Insulin antibodies in aetiology of labile diabetes. Lancet. 1972 Feb 12;1(7746):343–347. doi: 10.1016/s0140-6736(72)92841-3. [DOI] [PubMed] [Google Scholar]
- Dixon K., Exon P. D., Malins J. M. Insulin antibodies and the control of diabetes. Q J Med. 1975 Oct;44(176):543–553. [PubMed] [Google Scholar]
- Goodfriend T. L., Webster M. E., McGuire J. S. Complex effects of antibodies to polypeptide hormones. J Clin Endocrinol Metab. 1970 May;30(5):565–572. doi: 10.1210/jcem-30-5-565. [DOI] [PubMed] [Google Scholar]
- Heding L. G., Rasmussen S. M. Human C-peptide in normal and diabetic subjects. Diabetologia. 1975 Jun;11(3):201–206. doi: 10.1007/BF00422322. [DOI] [PubMed] [Google Scholar]